Genetic moderation of stress effects on corticolimbic circuitry

Neuropsychopharmacology

Volumn 41, Issue 1, 2016, Pages 275-296

  Bogdan, Ryan ^a   Pagliaccio, David ^b   Baranger, David A A ^a   Hariri, Ahmad R ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; FK 506 BINDING PROTEIN 5; STRESS HORMONE; UNCLASSIFIED DRUG;

BRAIN CORTEX; BRAIN FUNCTION; GENE REPLICATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIMBIC SYSTEM; MENTAL DISEASE; META ANALYSIS (TOPIC); MULTIFACTORIAL INHERITANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS; ANIMAL; GENETICS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INDIVIDUALITY; MENTAL STRESS; METABOLISM; NERVE CELL NETWORK; PHYSIOLOGY; PSYCHOLOGY;

ANIMALS; CEREBRAL CORTEX; GENE-ENVIRONMENT INTERACTION; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INDIVIDUALITY; LIMBIC SYSTEM; NERVE NET; PITUITARY-ADRENAL SYSTEM; STRESS, PSYCHOLOGICAL;

EID: 84949570889     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.216     Document Type: Review

References (246)

1. Agrawal A, Lynskey MT, Bucholz KK, Kapoor M, Almasy L, Dick DM et al (2014). DSM-5 cannabis use disorder: A phenotypic and genomic perspective. Drug Alcohol Depend 134: 362-369.
2. Alexander N, Klucken T, Koppe G, Osinsky R, Walter B, Vaitl D et al (2012). Interaction of the serotonin transporter-linked polymorphic region and environmental adversity: Increased amygdala-hypothalamus connectivity as a potential mechanism linking neural and endocrine hyperreactivity. Biol Psychiatry 72: 49-56.
3. Alfarez DN, Joels M, Krugers HJ (2003). Chronic unpredictable stress impairs longterm potentiation in rat hippocampal CA1 area and dentate gyrus in vitro. Eur J Neurosci 17: 1928-1934.
4. American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th edn. American Psychiatric Publishing, Inc.: Washington, DC, USA.
5. Andela CD, Van Haalen F, Ragnarsson O, Papakokkinou E, Johannsson G, Santos A et al (2015). Mechanisms in endocrinology: Cushing's syndrome causes irreversible effects on the human brain: A systematic review of structural and functional MRI studies. Eur J Endocrinol 173: R1-R14.
6. Andersen SL, Tomada A, Vincow ES, Valente E, Polcari A, Teicher MH (2008). Preliminary evidence for sensitive periods in the effect of childhood sexual abuse on regional brain development. J Neuropsychiatry Clin Neurosci 20: 292-301.
7. Andreasen NC, Wilcox MA, Ho BC, Epping E, Ziebell S, Zeien E et al (2012). Statistical epistasis and progressive brain change in schizophrenia: An approach for examining the relationships between multiple genes. Mol Psychiatry 17: 1093-1102.
8. Anisman H, Zaharia MD, Meaney MJ, Merali Z (1998). Do early-life events permanently alter behavioral and hormonal responses to stressors? Int J Dev Neurosci 16: 149-164.
9. Arloth J, Bogdan R, Weber P, Frishman G MA, Wagner KV, Schmidt MV et al (2015). Genetically determined differences in the immediate transcriptome response to stress predict risk-related brain function and psychiatric disorders. Neuron 86: 1189-1202.
10. Arnedo J, Svrakic DM, Del Val C, Romero-Zaliz R, Hernandez-Cuervo H, Molecular Genetics of Schizophrenia C et al (2015). Uncovering the hidden risk architecture of the schizophrenias: Confirmation in three independent genome-wide association studies. Am J Psychiatry 172: 139-153.
11. Barch DM, Burgess GC, Harms MP, Petersen SE, Schlaggar BL, Corbetta M et al (2013). Function in the human connectome: Task-fMRI and individual differences in behavior. NeuroImage 80: 169-189.
12. Bartzokis G, Mintz J, Marx P, Osborn D, Gutkind D, Chiang F et al (1993). Reliability of in vivo volume measures of hippocampus and other brain structures using MRI. Magn Reson Imaging 11: 993-1006.
13. Bastiaansen JA, Servaas MN, Marsman JBC, Ormel J, Nolte IM, Riese H et al (2014). Filling the gap: Relationship between the serotonin-transporter-linked polymorphic region and amygdala activation. Psychol Sci 25: 2058-2066.
14. Belsky J, Jonassaint C, Pluess M, Stanton M, Brummett B, Williams R (2009). Vulnerability genes or plasticity genes? Mol Psychiatry 14: 746-754.
15. Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T et al (2003). Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl 27: 169-190.
16. Bigos KL, Pollock BG, Aizenstein HJ, Fisher PM, Bies RR, Hariri AR (2008). Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology 33: 3221-3225.
17. Bilder RM, Volavka J, Lachman HM, Grace AA (2004). The catechol-Omethyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29: 1943-1961.
18. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB et al (2008). Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299: 1291-1305.
19. Binder EB, Nemeroff CB (2010). The CRF system, stress, depression and anxietyinsights from human genetic studies. Mol Psychiatry 15: 574-588.
20. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B et al (2004). Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36: 1319-1325.
21. Bogdan R, Agrawal A, Gaffrey MS, Tillman R, Luby JL (2014). Serotonin transporterlinked polymorphic region (5-HTTLPR) genotype and stressful life events interact to predict preschool-onset depression: A replication and developmental extension. J Child Psychol Psychiatry 55: 448-457.
22. Bogdan R, Hariri AR (2012a). Neural embedding of stress reactivity. Nat Neurosci 15: 1605-1607.
23. Bogdan R, Hyde LW, Hariri AR (2013a). A neurogenetics approach to understanding individual differences in brain, behavior, and risk for psychopathology. Mol Psychiatry 18: 288-299.
24. Bogdan R, Nikolova YS, Pizzagalli DA (2013b). Neurogenetics of depression: A focus on reward processing and stress sensitivity. Neurobiol Dis 52: 12-23.
25. Bogdan R, Santesso DL, Fagerness J, Perlis RH, Pizzagalli DA (2011). Corticotropinreleasing hormone receptor type 1 (CRHR1) genetic variation and stress interact to influence reward learning. J Neurosci 31: 13246-13254.
26. Bogdan R, Williamson DE, Hariri AR (2012b). Mineralocorticoid receptor Iso/Val (rs5522) genotype moderates the association between previous childhood emotional neglect and amygdala reactivity. Am J Psychiatry 169: 515-522.
27. Bolton JL, Hayward C, Direk N, Lewis JG, Hammond GL, Hill LA et al (2014). Genome wide association identifies common variants at the SERPINA6/SERPINA1 locus influencing plasma cortisol and corticosteroid binding globulin. PLos Genet 10: 7.
28. Booij L, Szyf M, Carballedo A, Frey EM, Morris D, Dymov S et al (2015). DNA methylation of the serotonin transporter gene in peripheral cells and stress-related changes in hippocampal volume: A study in depressed patients and healthy controls. PLoS One 10: E0119061.
29. Brown GW, Harris TO (1978). Social Origins of Depression: A Study of Psychiatric Disorder in Women. 1st edn. Free Press: New York, USA, xi, 399 pp.
30. Bruhl AB, Delsignore A, Komossa K, Weidt S (2014). Neuroimaging in social anxiety disorder-a meta-analytic review resulting in a new neurofunctional model. Neurosci Biobehav Rev 47: 260-280.
31. Bukalo O, Pinard CR, Holmes A (2014). Mechanisms to medicines: Elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders. Br J Pharmacol 171: 4690-4718.
32. Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR et al (2015). An atlas of genetic correlations across human diseases and traits. bioRxiv (http://dx.doi.org/10.1101/014498).
33. Burghy CA, Stodola DE, Ruttle PL, Molloy EK, Armstrong JM, Oler JA et al (2012). Developmental pathways to amygdala-prefrontal function and internalizing symptoms in adolescence. Nat Neurosci 15: 1736-1741.
34. Canli T, Qiu M, Omura K, Congdon E, Haas BW, Amin Z et al (2006). Neural correlates of epigenesis. Proc Natl Acad Sci USA 103: 16033-16038.
35. Cannon TD, Keller MC (2006). Endophenotypes in the genetic analyses of mental disorders. Annu Rev Clin Psychol 2: 267-290.
36. Carballedo A, Morris D, Zill P, Fahey C, Reinhold E, Meisenzahl E et al (2013). Brainderived neurotrophic factor Val66Met polymorphism and early life adversity affect hippocampal volume. Am J Med Genet B 162B: 183-190.
37. Carey CE, Agrawal A, Degenhardt L, Heath AC, Montgomery GW, Martin NG et al (in press). A monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. J Abnormal Psychol (e-pub ahead of print).
38. Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE (2010). Genetic sensitivity to the environment: The case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 167: 509-527.
39. Caspi A, Moffitt TE (2006). Gene-environment interactions in psychiatry: Joining forces with neuroscience. Nat Rev Neurosci 7: 583-590.
40. Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT et al (2011). Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 478: 519-523.
41. Cousijn H, Rijpkema M, Qin SZ, van Marle HJF, Franke B, Hermans EJ et al (2010). Acute stress modulates genotype effects on amygdala processing in humans. Proc Natl Acad Sci USA 107: 9867-9872.
42. Cyranoski D, Reardon S (2015). Embryo editing sparks epic debate. Nature 520: 593-594.
43. Dannlowski U, Kugel H, Redlich R, Halik A, Schneider I, Opel N et al (2014). Serotonin transporter gene methylation is associated with hippocampal gray matter volume. Hum Brain Mapp 35: 5356-5367.
44. de Kloet ER, Joels M, Holsboer F (2005). Stress and the brain: From adaptation to disease. Nat Rev Neurosci 6: 463-475.
45. de Kloet ER, Karst H, Joels M (2008). Corticosteroid hormones in the central stress response: Quick-and-slow. Front Neuroendocrin 29: 268-272.
46. de Quervain DJ, Kolassa IT, Ertl V, Onyut PL, Neuner F, Elbert T et al (2007). A deletion variant of the alpha2b-adrenoceptor is related to emotional memory in Europeans and Africans. Nat Neurosci 10: 1137-1139.
47. Dedovic K, Duchesne A, Andrews J, Engert V, Pruessner JC (2009). The brain and the stress axis: The neural correlates of cortisol regulation in response to stress. NeuroImage 47: 864-871.
48. DeRijk RH (2009). Single nucleotide polymorphisms related to HPA Axis reactivity. Neuroimmunomodulat 16: 340-352.
49. DeRijk RH, van Leeuwen N, Klok MD, Zitman FG (2008). Corticosteroid receptorgene variants: Modulators of the stress-response and implications for mental health. Eur J Pharmacol 585: 492-501.
50. DeRijk RH, Wust S, Meijer OC, Zennaro MC, Federenko IS, Hellhammer DH et al (2006). A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J Clin Endocr Metab 91: 5083-5089.
51. Di Iorio DR, Michalski LJ, Corral-Frias NS, Carey CE, Conley EC, Hariri AR et al Hypothalamic-pituitary-adrenal axis genetic variation moderates associations between early life stress and amygdala structure and function. (submitted).
52. Dick DM, Agrawal A, Keller MC, Adkins A, Aliev F, Monroe S et al (2015). Candidate gene-environment interaction research: Reflections and recommendations. Perspective Psychol Sci 10: 37-59.
53. Dincheva I, Drysdale AT, Hartley CA, Johnson DC, Jing D, King EC et al (2015). FAAH genetic variation enhances fronto-amygdala function in mouse and human. Nat Commun 6: 6395.
54. Dohrenwend BP (2000). The role of adversity and stress in psychopathology: Some evidence and its implications for theory and research. J Health Social Behav 41: 1-19.
55. Dohrenwend BP (2006). Inventorying stressful life events as risk factors for psychopathology: Toward resolution of the problem of intracategory variability. Psychol Bull 132: 477-495.
56. Doom JR, Gunnar MR (2013). Stress physiology and developmental psychopathology: Past, present, and future. Dev Psychopathol 25: 1359-1373.
57. Duncan LE, Keller MC (2011). A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. Am J Psychiatry 168: 1041-1049.
58. Duncan OD (1966). Path analysis: Sociological examples. Am J Sociol 72: 1-16.
59. Duvarci S, Pare D (2014). Amygdala microcircuits controlling learned fear. Neuron 82: 966-980.
60. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE et al (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98: 6917-6922.
61. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A et al (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112: 257-269.
62. Elzinga BM, Molendijk ML, Voshaar RCO, Bus BAA, Prickaerts J, Spinhoven P et al (2011). The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val(66)Met. Psychopharmacology 214: 319-328.
63. Fani N, Gutman D, Tone EB, Almli L, Mercer KB, Davis J et al (2013). FKBP5 and attention bias for threat associations with hippocampal function and shape. JAMA Psychiatry 70: 392-400.
64. Fani N, King TZ, Reiser E, Binder EB, Jovanovic T, Bradley B et al (2014). FKBP5 genotype and structural integrity of the posterior cingulum. Neuropsychopharmacology 39: 1206-1213.
65. Faravelli C, Lo Sauro C, Godini L, Lelli L, Benni L, Pietrini F et al (2012). Childhood stressful events, HPA axis and anxiety disorders. World J Psychiatry 2: 13-25.
66. Fardet L, Petersen I, Nazareth I (2012). Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry 169: 491-497.
67. Favaro A, Manara R, Pievani M, Clementi M, Forzan M, Bruson A et al (2014). Neural signatures of the interaction between the 5-HTTLPR genotype and stressful life events in healthy women. Psychiatry Res 223: 157-163.
68. Federenko IS, Nagamine M, Hellhammer DH, Wadhwa PD, Wust S (2004). The heritability of hypothalamus pituitary adrenal axis responses to psychosocial stress is context dependent. J Clin Endocr Metab 89: 6244-6250.
69. Flint J, Kendler KS (2014). The genetics of major depression. Neuron 81: 484-503.
70. Franz CE, York TP, Eaves LJ, Mendoza SP, Hauger RL, Hellhammer DH et al (2010). Genetic and environmental influences on cortisol regulation across days and contexts in middle-aged men. Behav Genet 40: 467-479.
71. Frodl T, Carballedo A, Frey EM, O'Keane V, Skokauskas N, Morris D et al (2014a). Expression of glucocorticoid inducible genes is associated with reductions in cornu ammonis and dentate gyrus volumes in patients with major depressive disorder. Dev Psychopathol 26: 1209-1217.
72. Frodl T, Carballedo A, Hughes MM, Saleh K, Fagan A, Skokauskas N et al (2012). Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: High IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder. Transl Psychiatry 2: E88.
73. Frodl T, Meisenzahl E, Zetzsche T, Bottlender R, Born C, Groll C et al (2002). Enlargement of the amygdala in patients with a first episode of major depression. Biol Psychiatry 51: 708-714.
74. Frodl T, Meisenzahl EM, Zetzsche T, Born C, Jager M, Groll C et al (2003). Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects. Biol Psychiatry 53: 338-344.
75. Frodl T, O'Keane V (2013). How does the brain deal with cumulative stress? A review with focus on developmental stress, HPA axis function and hippocampal structure in humans. Neurobiol Dis 52: 24-37.
76. Frodl T, Reinhold E, Koutsouleris N, Donohoe G, Bondy B, Reiser M et al (2010). Childhood stress, serotonin transporter gene and brain structures in major depression. Neuropsychopharmacology 35: 1383-1390.
77. Frodl T, Skokauskas N, Frey EM, Morris D, Gill M, Carballedo A (2014b). BDNF Val66Met genotype interacts with childhood adversity and influences the formation of hippocampal subfields. Hum Brain Mapp 35: 5776-5783.
78. Frodl T, Szyf M, Carballedo A, Ly V, Dymov S, Vaisheva F et al (2015). DNA methylation of the serotonin transporter gene (SLC6A4) is associated with brain function involved in processing emotional stimuli. J Psychiatry Neurosci 40: 140180.
79. Gaali S, Kirschner A, Cuboni S, Hartmann J, Kozany C, Balsevich G et al (2015). Selective inhibitors of the FK506-binding protein 51 by induced fit. Nat Chem Biol 11: 33.
80. Ganzel BL, Morris PA, Wethington E (2010). Allostasis and the human brain: Integrating models of stress from the social and life sciences. Psychol Rev 117: 134-174.
81. Gatt JM, Nemeroff CB, Dobson-Stone C, Paul RH, Bryant RA, Schofield PR et al (2009). Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry 14: 681-695.
82. Gee DG, Gabard-Durnam LJ, Flannery J, Goff B, Humphreys KL, Telzer EH et al (2013). Early developmental emergence of human amygdala-prefrontal connectivity after Maternal deprivation. Proc Natl Acad Sci USA 110: 15638-15643.
83. Gerritsen L, Tendolkar I, Franke B, Vasquez AA, Kooijman S, Buitelaar J et al (2012). BDNF Val66Met genotype modulates the effect of childhood adversity on subgenual anterior cingulate cortex volume in healthy subjects. Mol Psychiatry 17: 597-603.
84. Giedd JN, Raznahan A, Alexander-Bloch A, Schmitt E, Gogtay N, Rapoport JL (2015). Child psychiatry branch of the national institute of mental health longitudinal structural magnetic resonance imaging study of human brain development. Neuropsychopharmacology 40: 43-49.
85. Glover GH (2011). Overview of functional magnetic resonance imaging. Neurosurg Clin N Am 22: 133-139, vii.
86. Gorka AX, Hanson JL, Radtke SR, Hariri AR (2014). Reduced hippocampal and medial prefrontal gray matter mediate the association between reported childhood maltreatment and trait anxiety in adulthood and predict sensitivity to future life stress. Biol Mood Anxiety Disord 4: 12.
87. Gottesman II, Gould TD (2003). The endophenotype concept in psychiatry: Etymology and strategic intentions. Am J Psychiatry 160: 636-645.
88. Gray JM, Vecchiarelli HA, Morena M, Lee TT, Hermanson DJ, Kim AB et al (2015). Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety. J Neurosci 35: 3879-3892.
89. Green JG, McLaughlin KA, Berglund PA, Gruber MJ, Sampson NA, Zaslavsky AM et al (2010). Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: Associations with first onset of DSM-IV disorders. Arch Gen Psychiatry 67: 113-123.
90. Groenewold NA, Opmeer EM, de Jonge P, Aleman A, Costafreda SG (2013). Emotional valence modulates brain functional abnormalities in depression: Evidence from a meta-analysis of fMRI studies. Neurosci Biobehav Rev 37: 152-163.
91. Gunduz-Cinar O, Hill MN, McEwen BS, Holmes A (2013a). Amygdala FAAH and anandamide: Mediating protection and recovery from stress. Trends Pharmacol Sci 34: 637-644.
92. Gunduz-Cinar O, MacPherson KP, Cinar R, Gamble-George J, Sugden K, Williams B et al (2013b). Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Mol Psychiatry 18: 813-823.
93. Gustafsson PA, Gustafsson PE, Anckarsater H, Lichtenstein P, Ljung T, Nelson N et al (2011). Heritability of cortisol regulation in children. Twin Res Hum Genet 14: 553-561.
94. Hankin BL, Nederhof E, Oppenheimer CW, Jenness J, Young JF, Abela JRZ et al (2011). Differential susceptibility in youth: Evidence that 5-HTTLPR x positive parenting is associated with positive affect 'for better and worse'. Transl Psychiatry 1: E44.
95. Hanson JL, Nacewicz BM, Sutterer MJ, Cayo AA, Schaefer SM, Rudolph KD et al (2015). Behavioral problems after early life stress: Contributions of the hippocampus and amygdala. Biol Psychiatry 77: 314-323.
96. Hariri AR (2009). The neurobiology of individual differences in complex behavioral traits. Annu Rev Neurosci 32: 225-247.
97. Hariri AR (2015). Looking Inside the Disordered Brain: An Introduction to the Functional Neuroanatomy of Psychopathology. Sinauer Associates: Sunderland, MA, USA.
98. Hariri AR, Gorka A, Hyde LW, Kimak M, Halder I, Ducci F et al (2009). Divergent effects of genetic variation in endocannabinoid signaling on human threat-and reward-related brain function. Biol Psychiatry 66: 9-16.
99. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D et al (2002). Serotonin transporter genetic variation and the response of the human amygdala. Science 297: 400-403.
100. Hariri AR, Weinberger DR (2003). Imaging genomics. Br Med Bull 65: 259-270.
101. Hasler G, Drevets WC, Manji HK, Charney DS (2004). Discovering endophenotypes for major depression. Neuropsychopharmacology 29: 1765-1781.
102. Hauger RL, Risbrough V, Brauns O, Dautzenberg FM (2006). Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: New molecular targets. CNS Neurol Disord Drug Targets 5: 453-479.
103. Hauger RL, Risbrough V, Oakley RH, Olivares-Reyes JA, Dautzenberg FM (2009). Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann Ny Acad Sci 1179: 120-143.
104. Hayes JP, Vanelzakker MB, Shin LM (2012). Emotion and cognition interactions in PTSD: A review of neurocognitive and neuroimaging studies. Front Integr Neurosci 6: 89.
105. Heck A, Fastenrath M, Ackermann S, Auschra B, Bickel H, Coynel D et al (2014). Converging genetic and functional brain imaging evidence links neuronal excitability to working memory, psychiatric disease, and brain activity. Neuron 81: 1203-1213.
106. Henckens MJ, van Wingen GA, Joels M, Fernandez G (2010). Time-dependent effects of corticosteroids on human amygdala processing. J Neurosci 30: 12725-12732.
107. Henckens MJ, van Wingen GA, Joels M, Fernandez G (2011). Time-dependent corticosteroid modulation of prefrontal working memory processing. Proc Natl Acad Sci USA 108: 5801-5806.
108. Henckens MJ, van Wingen GA, Joels M, Fernandez G (2012). Corticosteroid induced decoupling of the amygdala in men. Cereb Cortex 22: 2336-2345.
109. Hernaus D, van Winkel R, Gronenschild E, Habets P, Kenis G, Marcelis M et al (2014). Brain-derived neurotrophic factor/FK506-binding protein 5 genotype by childhood trauma interactions do not impact on hippocampal volume and cognitive performance. PLoS One 9: 3.
110. Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivieres S, Jahanshad N et al (2015). Common genetic variants influence human subcortical brain structures. Nature 520: 224-229.
111. Hilbert K, Lueken U, Beesdo-Baum K (2014). Neural structures, functioning and connectivity in generalized anxiety disorder and interaction with neuroendocrine systems: A systematic review. J Affect Disord 158: 114-126.
112. Hill MN, Hellemans KG, Verma P, Gorzalka BB, Weinberg J (2012). Neurobiology of chronic mild stress: Parallels to major depression. Neurosci Biobehav Rev 36: 2085-2117.
113. Holmans P, Green EK, Pahwa JS, Ferreira MAR, Purcell SM, Sklar P et al (2009). Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet 85: 13-24.
114. Holmes AJ, Hollinshead MO, O'Keefe TM, Petrov VI, Fariello GR, Wald LL et al (2015). Brain Genomics Superstruct Project initial data release with structural, functional, and behavioral measures. Scientific Data 2, article number: 150031.
115. Holmes AJ, Lee PH, Hollinshead MO, Bakst L, Roffman JL, Smoller JW et al (2012). Individual differences in amygdala-medial prefrontal anatomy link negative affect, impaired social functioning, and polygenic depression risk. J Neurosci 32: 18087-18100.
116. Holz NE, Buchmann AF, Boecker R, Blomeyer D, Baumeister S, Wolf I et al (2014). Role of FKBP5 in emotion processing: Results on amygdala activity, connectivity and volume. Brain Struct Funct 220: 1355-1368.
117. Horowitz MA, Zunszain PA (2015). Neuroimmune and neuroendocrine abnormalities in depression: Two sides of the same coin. Ann NY Acad Sci (e-pub ahead of print).
118. Hyde LW, Bogdan R, Hariri AR (2011a). Understanding risk for psychopathology through imaging gene-environment interactions. Trends Cogn Sci 15: 417-427.
119. Hyde LW, Gorka A, Manuck SB, Hariri AR (2011b). Perceived social support moderates the link between threat-related amygdala reactivity and trait anxiety. Neuropsychologia 49: 651-656.
120. Iacono WG (2014). The molecular genetic basis for psychophysiological endophenotypes. Psychophsyiology 51, Special issue.
121. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K et al (2010). Research domain criteria (RDoC): Toward a new classification framework for research on mental disorders. Am J Psychiatry 167: 748-751.
122. Ising M, Holsboer F (2007). CRH1 receptor antagonists for the treatment of depression and anxiety. Exp Clin Psychopharm 15: 519-528.
123. Janak PH, Tye KM (2015). From circuits to behaviour in the amygdala. Nature 517: 284-292.
124. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012). A programmable dual-Rna-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821.
125. Johnson DC, Casey BJ (2015). Easy to remember, difficult to forget: The development of fear regulation. Dev Cogn Neurosci 11: 42-55.
126. Karg K, Burmeister M, Shedden K, Sen S (2011). The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: Evidence of genetic moderation. Arch Gen Psychiatry 68: 444-454.
127. Kaufman J (2015). The serotonin transporter gene and amygdala activation: Research in context. Biol Psychiatry (e-pub ahead of print).
128. Kehne JH, Cain CK (2010). Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: Evidence from animal models. Pharmacol Therapeut 128: 460-487.
129. Keller MC (2014). Gene x environment interaction studies have not properly controlled for potential confounders: The problem and the (simple) solution. Biol Psychiatry 75: 18-24.
130. Kempton MJ, Salvador Z, Munafo MR, Geddes JR, Simmons A, Frangou S et al (2011). Structural neuroimaging studies in major depressive disorder meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry 68: 675-690.
131. Kessler RC, McLaughlin KA, Green JG, Gruber MJ, Sampson NA, Zaslavsky AM et al (2010). Childhood adversities and adult psychopathology in the WHO World Mental Health Surveys. Br J Psychiatry 197: 378-385.
132. Kim MJ, Loucks RA, Palmer AL, Brown AC, Solomon KM, Marchante AN et al (2011). The structural and functional connectivity of the amygdala: From normal emotion to pathological anxiety. Behav Brain Res 223: 403-410.
133. Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM et al (2013). Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci 16: 33-41.
134. Klok MD, Alt SR, AJMI Lafitte, Turner JD, EAJF Lakke, Huitinga I et al (2011a). Decreased expression of mineralocorticoid receptor mRna and its splice variants in postmortem brain regions of patients with major depressive disorder. J Psychiat Res 45: 871-878.
135. Klok MD, Giltay EJ, Van der Does AJW, Geleijnse JM, Antypa N, BWJH Penninx et al (2011b). A common and functional mineralocorticoid receptor haplotype enhances optimism and protects against depression in females. Transl Psychiatry 1: E62.
136. Kolber BJ, Muglia LJ (2009). Defining brain region-specific glucocorticoid action during stress by conditional gene disruption in mice. Brain Res 1293: 85-90.
137. Lanphier E, Urnov F, Haecker SE, Werner M, Smolenski J (2015). Don't edit the human germ line. Nature 519: 410-411.
138. Lee PH, O'Dushlaine C, Thomas B, Purcell SM (2012). INRICH: Interval-based enrichment analysis for genome-wide association studies. Bioinformatics 28: 1797-1799.
139. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527-1531.
140. Lewinsohn PM, Rohde P, Seeley JR (1998). Major depressive disorder in older adolescents: Prevalence, risk factors, and clinical implications. Clin Psychol Rev 18: 765-794.
141. Li MX, Gui HS, Kwan JSH, Sham PC (2011). GATES: A rapid and powerful genebased association test using extended simes procedure. Am J Hum Genet 88: 283-293.
142. Li S, Weerda R, Milde C, Wolf OT, Thiel CM (2015). ADRA2B genotype differentially modulates stress-induced neural activity in the amygdala and hippocampus during emotional memory retrieval. Psychopharmacology 232: 755-764.
143. Liu JZ, McRae AF, Nyholt DR, Medland SE, Wray NR, Brown KM et al (2010). A versatile gene-based test for genome-wide association studies. AmJ Hum Genet 87: 139-145.
144. Luby J, Belden A, Botteron K, Marrus N, Harms MP, Babb C et al (2013). The effects of poverty on childhood brain development: The mediating effect of caregiving and stressful life events. JAMA Pediatr 167: 1135-1142.
145. Luby JL, Gaffrey MS, Tillman R, April LM, Belden AC (2014). Trajectories of preschool disorders to full DSM depression at school age and early adolescence: Continuity of preschool depression. Am J Psychiatry 171: 768-776.
146. Lucassen PJ, Pruessner J, Sousa N, Almeida OF, Van Dam AM, Rajkowska G et al (2014). Neuropathology of stress. Acta Neuropathol 127: 109-135.
147. Lupien SJ, McEwen BS, Gunnar MR, Heim C (2009). Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 10: 434-445.
148. Maheu FS, Mazzone L, Merke DP, Keil MF, Stratakis CA, Pine DS et al (2007). A fMRI study of amygdala and hippocampus function in adolescents with cushing syndrome. Biol Psychiatry 61: 62s-62s.
149. Maheu FS, Mazzone L, Merke DP, Keil M, Stratakis CA, Pine DS et al (2008). Altered amygdala and hippocampus function in adolescents with hypercortisolemia: A functional magnetic resonance imaging study of Cushing syndrome. Dev Psychopathol 20: 1177-1189.
150. Manuck SB, Brown SM, Forbes EE, Hariri AR (2007). Temporal stability of individual differences in amygdala reactivity. Am J Psychiatry 164: 1613-1614.
151. Marques AH, Silverman MN, Sternberg EM (2009). Glucocorticoid dysregulations and their clinical correlates from receptors to therapeutics. Ann NY Acad Sci 1179: 1-18.
152. McCrory E, De Brito SA, Viding E (2011). The impact of childhood maltreatment: A review of neurobiological and genetic factors. Front Psychiatry 2: 48.
153. McEwen BS (2000). Allostasis and allostatic load: Implications for neuropsychopharmacology. Neuropsychopharmacology 22: 108-124.
154. McEwen BS (2003). Mood disorders and allostatic load. Biol Psychiatry 54: 200-207.
155. McEwen BS, Gianaros PJ (2010). Central role of the brain in stress and adaptation: Links to socioeconomic status, health, and disease. Ann NY Acad Sci 1186: 190-222.
156. McEwen BS, Gianaros PJ (2011). Stress-and allostasis-induced brain plasticity. Annu Rev Med 62: 431-445.
157. McEwen BS, Morrison JH (2013). The brain on stress: Vulnerability and plasticity of the prefrontal cortex over the life course. Neuron 79: 16-29.
158. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonte B, Szyf M et al (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12: 342-348.
159. Mehta MA, Golembo NI, Nosarti C, Colvert E, Mota A, Williams SC et al (2009). Amygdala, hippocampal and corpus callosum size following severe early institutional deprivation: The English and Romanian Adoptees study pilot. J Child Psychol Psychiatry 50: 943-951.
160. Menke A, Arloth J, Putz B, Weber P, Klengel T, Mehta D et al (2012). Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients. Neuropsychopharmacology 37: 1455-1464.
161. Meyer-Lindenberg A, Weinberger DR (2006). Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7: 818-827.
162. Miller GE, Chen E, Zhou ES (2007). If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol Bull 133: 25-45.
163. Mitra R, Ferguson D, Sapolsky RM (2009). Mineralocorticoid receptor overexpression in basolateral amygdala reduces corticosterone secretion and anxiety. Biol Psychiatry 66: 686-690.
164. Moffitt TE, Caspi A (2014). Bias in a protocol for a meta-analysis of 5-HTTLPR, stress, and depression. BMC Psychiatry 14: 179.
165. Molendijk ML, Bus BAA, Spinhoven P, Kaimatzoglou A, Voshaar RCO, BW Pennix et al (2012). A systematic review and meta-analysis on the association between BDNF val(66)met and hippocampal volume-a genuine effect or a winners curse? Am J Med Genet B 159B: 731-740.
166. Monroe SM (2008). Modern approaches to conceptualizing and measuring human life stress. Annu Rev Clin Psychol 4: 33-52.
167. Monroe SM, Reid MW (2009). Life stress and major depression. Curr Dir Psychol Sci 18: 68-72.
168. Munafo MR, Bowes L, Clark TG, Flint J (2005). Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: A meta-analysis of case-control studies. Mol Psychiatry 10: 765-770.
169. Murphy SE, Norbury R, Godlewska BR, Cowen PJ, Mannie ZM, Harmer CJ et al (2013). The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: A meta-analysis. Mol Psychiatry 18: 512-520.
170. Nakamura K, Brown RA, Narayanan S, Collins DL, Arnold DL, Alzheimer's Disease Neuroimaging I (2015). Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations. NeuroImage 118: 126-132.
171. Nikolova YS, Bogdan R, Brigidi BD, Hariri AR (2012). Ventral striatum reactivity to reward and recent life stress interact to predict positive affect. Biol Psychiatry 72: 157-163.
172. Nikolova YS, Ferrell RE, Manuck SB, Hariri AR (2011). Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity. Neuropsychopharmacology 36: 1940-1947.
173. Nikolova YS, Hariri AR (2015). Can we observe epigenetic effects on human brain function? Trends Cogn Sci 19: 366-373.
174. Nikolova YS, Koenen KC, Galea S, Wang CM, Seney ML, Sibille E et al (2014). Beyond genotype: Serotonin transporter epigenetic modification predicts human brain function. Nat Neurosci 17: 1153-1155.
175. Otte C, Hinkelmann K, Moritz S, Yassouridis A, Jahn H, Wiedemann K et al (2010). Modulation of the mineralocorticoid receptor as add-on treatment in depression: A randomized, double-blind, placebo-controlled proof-of-concept study. J Psychiat Res 44: 339-346.
176. Pagliaccio D, Luby JL, Bogdan R, Agrawal A, Gaffrey MS, Belden AC et al (2014). Stress-system genes and life stress predict cortisol levels and amygdala and hippocampal volumes in children. Neuropsychopharmacology 39: 1245-1253.
177. Pagliaccio D, Luby JL, Bogdan R, Agrawal A, Gaffrey MS, Belden AC et al (2015). HPA axis genetic variation, pubertal status, and sex interact to predict amygdala and hippocampus responses to negative emotional faces in school-age children. NeuroImage 109C: 1-11.
178. Pariante CM, Lightman SL (2008). The HPA axis in major depression: Classical theories and new developments. Trends Neurosci 31: 464-468.
179. Patten SB, Neutel CI (2000). Corticosteroid-induced adverse psychiatric effects: Incidence, diagnosis and management. Drug Safety 22: 111-122.
180. Pearson R, McGeary JE, Beevers CG (2014). Association between serotonin cumulative genetic score and the behavioral approach system (BAS): Moderation by early life environment. Pers Individ Dif 70: 140-144.
181. Pecin?a M, Martínez-Jauand M, Love T, HefFernan J, Montoya P, Hodgkinson C et al (2014). Valence-specific effects of BDNF Val66Met polymorphism on dopaminergic stress and reward processing in humans. J Neurosci 34: 5874-5881.
182. Pelizza L, Ferrari A (2009). Anhedonia in schizophrenia and major depression: State or trait? Ann Gen Psychiatry 8: 22.
183. Plichta MM, Grimm O, Morgen K, Mier D, Sauer C, Haddad L et al (2014). Amygdala habituation: A reliable fMRI phenotype. NeuroImage 103: 383-390.
184. Plichta MM, Schwarz AJ, Grimm O, Morgen K, Mier D, Haddad L et al (2012). Testretest reliability of evoked BOLD signals from a cognitive-emotive fMRI test battery. NeuroImage 60: 1746-1758.
185. Price JL, Drevets WC (2012). Neural circuits underlying the pathophysiology of mood disorders. Trends Cogn Sci 16: 61-71.
186. Purcell SM, Wray WR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF et al (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752.
187. Qin S, Cousijn H, Rijpkema M, Luo J, Franke B, Hermans EJ et al (2012). The effect of moderate acute psychological stress on working memory-related neural activity is modulated by a genetic variation in catecholaminergic function in humans. Front Integr Neurosci 6: 16.
188. Rabl U, Meyer BM, Diers K, Bartova L, Berger A, Mandorfer D et al (2014). Additive gene-environment effects on hippocampal structure in healthy humans. J Neurosci 34: 9917-9926.
189. Rasch B, Spalek K, Buholzer S, Luechinger R, Boesiger P, Papassotiropoulos A et al (2009). A genetic variation of the noradrenergic system is related to differential amygdala activation during encoding of emotional memories. Proc Natl Acad Sci USA 106: 19191-19196.
190. Rose EJ, Donohoe G (2013). Brain vs behavior: An effect size comparison of neuroimaging and cognitive studies of genetic risk for schizophrenia. Schizophrenia Bull 39: 518-526.
191. Sander JD, Joung JK (2014). CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 32: 347-355.
192. Sauder CL, Hajcak G, Angstadt M, Phan KL (2013). Test-retest reliability of amygdala response to emotional faces. Psychophysiology 50: 1147-1156.
193. Scharf SH, Liebl C, Binder EB, Schmidt MV, Muller MB (2011). Expression and regulation of the Fkbp5 gene in the adult mouse brain. PLoS One 6: E16883.
194. Schizophrenia Working Group of the Psychiatric Genomics C (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature 511: 421-427.
195. Schumann G, Loth E, Banaschewski T, Barbot A, Barker G, Buchel C et al (2010). The IMAGEN study: Reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry 15: 1128-1139.
196. Segre AV, Groop L, Mootha VK, Daly MJ, Altshuler D, Consortium D et al (2010). Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet 6: Pii.
197. Selye H (1936). A syndrome produced by diverse nocuous agents. Nature 138: 32-32.
198. Sharpley CF, Palanisamy SK, Glyde NS, Dillingham PW, Agnew LL (2014). An update on the interaction between the serotonin transporter promoter variant (5-HTTLPR), stress and depression, plus an exploration of non-confirming findings. Behav Brain Res 273: 89-105.
199. Sheridan MA, Fox NA, Zeanah CH, McLaughlin KA, Nelson CA 3rd (2012). Variation in neural development as a result of exposure to institutionalization early in childhood. Proc Natl Acad Sci USA 109: 12927-12932.
200. Shirtcliff EA, Allison AL, Armstrong JM, Slattery MJ, Kalin NH, Essex MJ (2012). Longitudinal stability and developmental properties of salivary cortisol levels and circadian rhythms from childhood to adolescence. Dev Psychobiol 54: 493-502.
201. Slavich GM, Epel ES (2010). The Stress and Adversity Inventory (STRAIN): An automated system for assessing cumulative stress exposure. Laboratory for Stress Assessment and Research. UCLA: Los Angeles, CA, USA.
202. Slavich GM, Tartter MA, Brennan PA, Hammen C (2014). Endogenous opioid system influences depressive reactions to socially painful targeted rejection life events. Psychoneuroendocrinology 49: 141-149.
203. Small KM, Brown KM, Forbes SL, Liggett SB (2001). Polymorphic deletion of three intracellular acidic residues of the alpha 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J Biol Chem 276: 4917-4922.
204. Smoller JW, Craddock N, Kendler K, Lee PH, Neale BM, Nurnberger JI et al (2013). Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet 381: 1371-1379.
205. Sousa N, Lukoyanov NV, Madeira MD, Almeida OFX, Paula-Barbosa MM (2000). Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience 97: 253-266.
206. Streit F, Haddad L, Paul T, Frank J, Schafer A, Nikitopoulos J et al (2014). A functional variant in the nEuropeptide S receptor 1 gene moderates the influence of urban upbringing on stress processing in the amygdala. Stress 17: 352-361.
207. Swartz JR, Knodt AR, Radtke SR, Hariri AR (2015). A neural biomarker of psychological vulnerability to future life stress. Neuron 85: 505-511.
208. Swartz JR, Monk CS (2014a). The role of corticolimbic circuitry in the development of anxiety disorders in children and adolescents. Curr Top Behav Neurosci 16: 133-148.
209. Swartz JR, Williamson DE, Hariri AR (2014b). Developmental change in amygdala reactivity during adolescence: Effects of family history of depression and stressful life events. Am J Psychiatry 172: 276-283, appiajp2 01414020195.
210. Tan HY, Chen Q, Sust S, Buckholtz JW, Meyers JD, Egan MF et al (2007). Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proc Natl Acad Sci USA 104: 12536-12541.
211. Tarullo AR, Gunnar MR (2006). Child maltreatment and the developing HPA axis. Horm Behav 50: 632-639.
212. Teicher MH, Andersen SL, Polcari A, Anderson CM, Navalta CP, Kim DM (2003). The neurobiological consequences of early stress and childhood maltreatment. Neurosci Biobehav Rev 27: 33-44.
213. Teicher MH, Samson JA (2013). Childhood maltreatment and psychopathology: A case for ecophenotypic variants as clinically and neurobiologically distinct subtypes. Am J Psychiatry 170: 1114-1133.
214. Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria ME et al (2014). The ENIGMA consortium: Large-scale collaborative analyses of neuroimaging and genetic data. Brain Imag Behav 8: 153-182.
215. Thomson F, Craighead M (2008). Innovative approaches for the treatment of depression: Targeting the HPA axis. Neurochem Res 33: 691-707.
216. Tottenham N, Hare TA, Millner A, Gilhooly T, Zevin JD, Casey BJ (2011). Elevated amygdala response to faces following early deprivation. Dev Sci 14: 190-204.
217. Tottenham N, Hare TA, Quinn BT, McCarry TW, Nurse M, Gilhooly T et al (2010). Prolonged institutional rearing is associated with atypically large amygdala volume and difficulties in emotion regulation. Dev Sci 13: 46-61.
218. Tottenham N, Sheridan MA (2009). A review of adversity, the amygdala and the hippocampus: A consideration of developmental timing. Front Hum Neurosci 3: 68.
219. Turecki G, Meaney MJ (in press). Effects of the social environment and stress on glucocorticoid receptor gene methylation: A systematic review. Biol Psychiatry.
220. Tyrka AR, Burgers DE, Philip NS, Price LH, Carpenter LL (2013). The neurobiological correlates of childhood adversity and implications for treatment. Acta Psychiat Scand 128: 434-447.
221. Ulrich-Lai YM, Herman JP (2009). Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 10: 397-409.
222. Urry HL, van Reekum CM, Johnstone T, Kalin NH, Thurow ME, Schaefer HS et al (2006). Amygdala and ventromedial prefrontal cortex are inversely coupled during regulation of negative affect and predict the diurnal pattern of cortisol secretion among older adults. J Neurosci 26: 4415-4425.
223. Ursini G, Bollati V, Fazio L, Porcelli A, Iacovelli L, Catalani A et al (2011). Stressrelated methylation of the catechol-O-methyltransferase val(158) allele predicts human prefrontal cognition and activity. J Neurosci 31: 6692-6698.
224. Van Hulle CA, Shirtcliff EA, Lemery-Chalfant K, Goldsmith HH (2012). Genetic and environmental influences on individual differences in cortisol level and circadian rhythm in middle childhood. Horm Behav 62: 36-42.
225. van Leeuwen N, Bellingrath S, de Kloet ER, Zitman FG, DeRijk RH, Kudielka BM et al (2011). Human mineralocorticoid receptor (MR) gene haplotypes modulate MR expression and transactivation: Implication for the stress response. Psychoeuroendocrinology 36: 699-709.
226. van Leeuwen N, Kumsta R, Entringer S, de Kloet ER, Zitman FG, DeRijk RH et al (2010). Functional mineralocorticoid receptor (MR) gene variation influences the cortisol awakening response after dexamethasone. Psychoneuroendocrinology 35: 339-349.
227. Verhagen M, van der Meij A, van Deurzen PAM, Janzing JGE, Arias-Vasquez A, Buitelaar JK et al (2010). Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: Effects of gender and ethnicity. Mol Psychiatry 15: 260-271.
228. Vogel S, Klumpers F, Krugers HJ, Fang Z, Oplaat KT, Oitzl MS et al (2015). Blocking the mineralocorticoid receptor in humans prevents the stress-induced enhancement of centromedial amygdala connectivity with the dorsal striatum. Neuropsychopharmacology 40: 947-956.
229. Wada K, Yamada N, Suzuki H, Lee Y, Kuroda S (2000). Recurrent cases of corticosteroid-induced mood disorder: Clinical characteristics and treatment. J Clin Psychiatry 61: 261-267.
230. Wardle MC, de Wit H, Penton-Voak I, Lewis G, Munafo MR (2013). Lack of association between COMT and working memory in a population-based cohort of healthy young adults. Neuropsychopharmacology 38: 1253-1263.
231. Weaver ICG, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Jr S et al (2004). Epigenetic programming by Maternal behavior. Nat Neurosci 7: 847-854.
232. Weaver ICG, Champagne FA, Brown SE, Dymov S, Sharma S, Meaney MJ et al (2005). Reversal of Maternal programming of stress responses in adult offspring through methyl supplementation: Altering epigenetic marking later in life. J Neurosci 25: 11045-11054.
233. Whalen PJ, Phelps EA (2009). The Human Amygdala. Guilford Press: New York, USA, xiv, 429 p, 416 p of plates.
234. White MG, Bogdan R, Fisher PM, Munoz KE, Williamson DE, Hariri AR (2012). FKBP5 and emotional neglect interact to predict individual differences in amygdala reactivity. Genes Brain Behav 11: 869-878.
235. Williams LM, Gatt JM, Schofield PR, Olivieri G, Peduto A, Gordon E (2009). 'Negativity bias' in risk for depression and anxiety: Brain-body fear circuitry correlates, 5-HTT-LPR and early life stress. NeuroImage 47: 804-814.
236. Williamson DE, Birmaher B, Ryan ND, Shiffrin TP, Lusky JA, Protopapa J et al (2003). The stressful life events schedule for children and adolescents: Development and validation. Psychiatry Res 119: 225-241.
237. Wright S (1920). Correlation and causation part I. Method of path coefficients. J Agric Res 20: 0557-0585.
238. Wust S, Federenko I, Hellhammer DH, Kirschbaum C (2000). Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 25: 707-720.
239. Xu K, Seo D, Hodgkinson C, Hu Y, Goldman D, Sinha R (2013). A variant on the kappa opioid receptor gene (OPRK1) is associated with stress response and related drug craving, limbic brain activation and cocaine relapse risk. Transl Psychiatry 3.
240. Zannas AS, Binder EB (2014). Gene-environment interactions at the FKBP5 locus: Sensitive periods, mechanisms and pleiotropism. Genes Brain Behav 13: 25-37.
241. Zannas AS, McQuoid DR, Payne ME, Steffens DC, MacFall JR, Ashley-Koch A et al (2013). Negative life stress and longitudinal hippocampal volume changes in older adults with and without depression. J Psychiat Res 47: 829-834.
242. Zhou X, Lowdon RF, Li D, Lawson HA, Madden PAF, Costello JF et al (2013). Exploring long-range genome interactions using the WashU epigenome browser. Nat Methods 10: 375-376.
243. Zhou X, Maricque B, Xie MC, Li DF, Sundaram V, Martin EA et al (2011). The human epigenome browser at Washington university. Nat Methods 8: 989-990.
244. Ziegler C, Dannlowski U, Brauer D, Stevens S, Laeger I, Wittmann H et al (2015). Oxytocin receptor gene methylation: Converging multilevel evidence for a role in social anxiety. Neuropsychopharmacology 40: 1528-1538.
245. Zimmermann P, Bruckl T, Nocon A, Pfister H, Binder EB, Uhr M et al (2011). Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: Results from a 10-year prospective community study. Am J Psychiatry 168: 1107-1116.
246. Zuo XN, Anderson JS, Bellec P, Birn RM, Biswal BB, Blautzik J et al (2014). An open science resource for establishing reliability and reproducibility in functional connectomics. Scientific Data 1: 140049.